Class information for:
Level 1: LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19803 425 29.0 54%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1055 9558 CISPLATIN//NAMI A//NEPHROTOXICITY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEHRSTUHL PHARMAZEUT CHEM 2 Address 31 92% 3% 12
2 GRP RECH ONCOL ENDOCRINOL MOL Address 11 69% 2% 9
3 PORPHYRIN PLATINUM CONJUGATES Author keyword 6 100% 1% 4
4 ESTROGEN RECEPTOR AFFINITY Author keyword 4 67% 1% 4
5 ZINDOXIFENE Author keyword 3 100% 1% 3
6 SALOPHENE Author keyword 2 67% 0% 2
7 GRP RECH BIOPATHOL CELLULAI MOL Address 2 36% 1% 4
8 1 2 BIS2 6 DIFLUORO 3 HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII COMPLEXES Author keyword 1 100% 0% 2
9 1 3 DIPHENYLPROPANE 1 3 DIAMINES Author keyword 1 50% 0% 2
10 CANADA CHAIR MOL GYNECOONCOL Address 1 50% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 PORPHYRIN PLATINUM CONJUGATES 6 100% 1% 4 Search PORPHYRIN+PLATINUM+CONJUGATES Search PORPHYRIN+PLATINUM+CONJUGATES
2 ESTROGEN RECEPTOR AFFINITY 4 67% 1% 4 Search ESTROGEN+RECEPTOR+AFFINITY Search ESTROGEN+RECEPTOR+AFFINITY
3 ZINDOXIFENE 3 100% 1% 3 Search ZINDOXIFENE Search ZINDOXIFENE
4 SALOPHENE 2 67% 0% 2 Search SALOPHENE Search SALOPHENE
5 1 2 BIS2 6 DIFLUORO 3 HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII COMPLEXES 1 100% 0% 2 Search 1+2+BIS2+6+DIFLUORO+3+HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII+COMPLEXES Search 1+2+BIS2+6+DIFLUORO+3+HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII+COMPLEXES
6 1 3 DIPHENYLPROPANE 1 3 DIAMINES 1 50% 0% 2 Search 1+3+DIPHENYLPROPANE+1+3+DIAMINES Search 1+3+DIPHENYLPROPANE+1+3+DIAMINES
7 DUNNING R3327 G TUMOR 1 50% 0% 2 Search DUNNING+R3327+G+TUMOR Search DUNNING+R3327+G+TUMOR
8 MESO 1 2 BIS2 6 DICHLORO 4 HYDROXYPHENYLETHYLENEDIAMINEDICHLOROPLATINUMII 1 100% 0% 2 Search MESO+1+2+BIS2+6+DICHLORO+4+HYDROXYPHENYLETHYLENEDIAMINEDICHLOROPLATINUMII Search MESO+1+2+BIS2+6+DICHLORO+4+HYDROXYPHENYLETHYLENEDIAMINEDICHLOROPLATINUMII
9 MXT M 3 2 BREAST CANCER 1 100% 0% 2 Search MXT+M+3+2+BREAST+CANCER Search MXT+M+3+2+BREAST+CANCER
10 CISPLATIN ANALOGS 1 30% 1% 3 Search CISPLATIN+ANALOGS Search CISPLATIN+ANALOGS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DEPENDENT MAMMARY CARCINOMA 34 93% 3% 13
2 1 2 BIS2 6 DIHALO 3 HYDROXYPHENYLETHYLENEDIAMINEPLATINUMII COMPLEXES 14 100% 2% 7
3 INHIBITING 1 2 BISFLUOROPHENYLETHYLENEDIAMINEPLATINUMII COMPLEXES 12 75% 2% 9
4 TUMOR INHIBITING ACTIVITY 12 48% 4% 19
5 TUMOR INHIBITING PROPERTIES 8 60% 2% 9
6 ANTITUMOR ESTRADIOL PLATINUMII HYBRID 8 100% 1% 5
7 ACETOXY SUBSTITUTED 1 1 2 TRIPHENYLBUT 1 ENES 6 71% 1% 5
8 CYTOCIDAL ACTIVITY 6 58% 2% 7
9 2 PHENYL RING 5 63% 1% 5
10 VARIABLE SUBSTITUENTS 5 63% 1% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Optimization of cisplatin for the treatment of hormone-dependent tumoral diseases Part 2: Use of non-steroidal ligands 2009 17 114 82%
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases Part 1: Use of steroidal ligands 2009 35 123 41%
Progress in Synthesis and Antitumor Activities of Estradiol-linked Platinum Complex 2013 3 40 40%
PLATINUM COMPOUNDS WITH ESTROGEN-RECEPTOR AFFINITY 1990 17 12 75%
Rational drug design 2009 37 33 15%
The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View 2009 31 243 17%
Platinum complexes of 1,3-diphenylpropane-1,3-diamines-cytostatic compounds? 1996 0 13 77%
Targeting the Estrogen Receptor using Steroid-Therapeutic Drug Conjugates (Hybrids) 2012 10 129 12%
Synthesis of Transition-Metal Steroid Derivatives 2013 3 295 12%
Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM) 2009 6 83 17%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEHRSTUHL PHARMAZEUT CHEM 2 31 92% 2.8% 12
2 GRP RECH ONCOL ENDOCRINOL MOL 11 69% 2.1% 9
3 GRP RECH BIOPATHOL CELLULAI MOL 2 36% 0.9% 4
4 CANADA CHAIR MOL GYNECOONCOL 1 50% 0.5% 2
5 GRBCM 1 50% 0.5% 2
6 LEHRSTUHL PHARMACEUT CHEM 2 1 100% 0.5% 2
7 IMMUNOBIOL STEM CELL 1 25% 0.7% 3
8 EXPTL CHEMOTHER Y TOSHIMA KU 1 33% 0.5% 2
9 MOL BIOSCI INNSBRUCKCCB 1 33% 0.5% 2
10 GRP MOL CELLULAR BIOPATHOL 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000166974 AEBS//ANTIESTROGEN BINDING SITES//ANALOG II
2 0.0000163246 SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS
3 0.0000156911 PLATINUM BASED DRUG//JM216//PLATINUM COMPLEXES
4 0.0000144517 FLUOROESTRADIOL//F 18 FES PET//FES PET
5 0.0000076347 CORNCOB BEDDING//TYPE II SITES//TYPE II ESTROGEN BINDING SITES
6 0.0000067594 HOMO AZA STEROIDAL ESTERS//STEROIDAL ESTERS//HOMO AZA STEROIDS
7 0.0000067541 BIOORGANOMETALLIC CHEMISTRY//FERROCIFEN//FERROCENYLALKYLATION
8 0.0000064467 BIOACTIVE ALKALOID//CORYDALIS OCHOTENSIS//N BENZYL INDOLE
9 0.0000063151 METAL CARBONYL TRACER//METAL CONFIGURATION//UMR 7576
10 0.0000058304 SARCNU//TAUROMUSTINE//S 2250 KAWAGISHI